We are live on ! Find out more
AFA

Arlington Financial Advisors Portfolio holdings

AUM $787M
1-Year Est. Return 22.93%
This Fund
S&P 500
This Quarter Est. Return
-0.74%
1 Year Est. Return
+22.93%
3 Year Est. Return
+60.65%
5 Year Est. Return
+68.7%
10 Year Est. Return
AUM
$503M
AUM Growth
+$16M
Cap. Flow
+$24.2M
Cap. Flow %
4.82%
Top 10 Hldgs %
49.21%
Holding
93
New
22
Increased
27
Reduced
31
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 6.61%
2 Financials 4.34%
3 Consumer Discretionary 3.92%
4 Healthcare 3.71%
5 Communication Services 3.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGIT icon
76
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.6B
$315K 0.06%
5,428
ASML icon
77
ASML
ASML
$631B
$312K 0.06%
450
-35
-7% -$25.1K
XPH icon
78
State Street SPDR S&P Pharmaceuticals ETF
XPH
$491M
$291K 0.06%
+6,762
New +$307K
AVGO icon
79
Broadcom
AVGO
$1.87T
$290K 0.06%
+1,250
New +$231K
NVDA icon
80
NVIDIA
NVDA
$5.01T
$266K 0.05%
1,982
-18
-0.9% -$2.48K
IWD icon
81
iShares Russell 1000 Value ETF
IWD
$82.6B
$265K 0.05%
+1,434
New +$275K
DWM icon
82
WisdomTree International Equity Fund
DWM
$682M
$258K 0.05%
+4,887
New +$268K
AVGE icon
83
Avantis All Equity Markets ETF
AVGE
$1.12B
$249K 0.05%
3,435
-290
-8% -$21.6K
VEEV icon
84
Veeva Systems
VEEV
$33.5B
$247K 0.05%
1,173
SPBO icon
85
State Street SPDR Portfolio Corporate Bond ETF
SPBO
$2.09B
$237K 0.05%
8,264
APPF icon
86
AppFolio
APPF
$6.79B
$235K 0.05%
952
SCHM icon
87
Schwab US Mid-Cap ETF
SCHM
$14.7B
$228K 0.05%
8,244
-633
-7% -$18K
IDXX icon
88
Idexx Laboratories
IDXX
$44.8B
$227K 0.05%
550
-211
-28% -$92.5K
IOO icon
89
iShares Global 100 ETF
IOO
$9.05B
$219K 0.04%
+2,177
New +$219K
VRTX icon
90
Vertex Pharmaceuticals
VRTX
$119B
$215K 0.04%
535
+35
+7% +$16.2K
DKS icon
91
Dick's Sporting Goods
DKS
$18B
$211K 0.04%
+922
New +$193K
MSCI icon
92
MSCI
MSCI
$41.8B
$210K 0.04%
+350
New +$210K
CRSP icon
93
CRISPR Therapeutics
CRSP
$4.88B
-4,263
Closed -$200K

Similar funds

Arlington Financial Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Arlington Financial Advisors held 93 positions worth $503M, up 3.3% from $487M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Arlington Financial Advisors deployed $24.2M of net new capital in Q4 2024, opening 22 new positions and adding to 27 existing holdings. Its largest new stake was Vanguard FTSE Developed Markets ETF: 442,522 shares worth $21.2M.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, up from 6.4% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Harbor International Compounders ETF, an estimated $20.5M trimmed.

  • Arlington Financial Advisors's largest Q4 2024 buy was Vanguard FTSE Developed Markets ETF: 442,522 shares worth $21.2M.
  • Arlington Financial Advisors added most to Invesco FTSE RAFI Developed Markets ex-US ETF in Q4 2024, an estimated $2.32M increase.
  • Arlington Financial Advisors's biggest Q4 2024 reduction was Harbor International Compounders ETF, cutting an estimated $20.5M.
  • Arlington Financial Advisors fully exited CRISPR Therapeutics in Q4 2024, selling an estimated $200K.
  • Arlington Financial Advisors's ten largest holdings make up 49% of its $503M portfolio in Q4 2024.
  • Arlington Financial Advisors opened 22 new positions and closed 1 in Q4 2024.
  • Arlington Financial Advisors's portfolio value rose 3.3% quarter-over-quarter to $503M.

Based on Arlington Financial Advisors's 13F filing for Q4 2024, filed 28 Jan 2025.